Related Experiment Video
Updated: Dec 25, 2025

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells
Nicolas Espagnolle1,2, Benjamin Hebraud3, Jean-Gérard Descamps1,2
1STROMALab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France.
Adipose stromal cells (ASCs) from multiple myeloma (MM) patients show fewer abnormalities than mesenchymal stromal cells (MSCs). However, their potential use in MM bone repair requires further safety and efficacy investigation.
Area of Science:
- Hematology
- Oncology
- Regenerative Medicine
Background:
- Multiple myeloma (MM) is a B cell neoplasm causing bone lesions due to abnormal bone marrow mesenchymal stromal cells (MSCs).
- Adipose stromal cells (ASCs) are explored as an alternative for cellular therapy in MM bone repair.
Purpose of the Study:
- To compare adipose stromal cells (ASCs) from multiple myeloma (MM) patients with those from healthy donors (HDs).
- To evaluate ASCs' potential for repairing MM-induced bone damage.
Main Methods:
- Transcriptomic, phenotypic, and functional analyses of ASCs and MSCs from MM patients and HDs.
- Comparison of MM ASCs against autologous MM MSCs and HD counterparts.
Main Results:
- MM ASCs exhibited fewer abnormalities compared to MM MSCs.
- Observed changes in MM ASCs and their supportive effect on MM cells raise safety concerns for autologous or allogeneic use.
Conclusions:
- MM ASCs may not be inherently abnormal like MM MSCs.
- Further research is needed to assess the safety and efficacy of ASCs for treating MM bone lesions.
More Related Videos
13:26Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
Published on: March 31, 2018
11:31Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
Published on: October 31, 2012